Wellington Management Group LLP raised its stake in Evolent Health, Inc. (NYSE:EVH – Free Report) by 96.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 8,313,157 shares of the technology company’s stock after purchasing an additional 4,073,959 shares during the quarter. Wellington Management Group LLP owned about 7.20% of Evolent Health worth $274,584,000 at the end of the most recent quarter.
Other hedge funds also recently made changes to their positions in the company. Chicago Partners Investment Group LLC acquired a new position in shares of Evolent Health during the 4th quarter valued at $228,000. First Light Asset Management LLC acquired a new position in shares of Evolent Health during the 4th quarter valued at $2,699,000. Point72 Asset Management L.P. lifted its holdings in shares of Evolent Health by 81.3% during the 4th quarter. Point72 Asset Management L.P. now owns 2,675,000 shares of the technology company’s stock valued at $88,355,000 after acquiring an additional 1,199,400 shares in the last quarter. Rhenman & Partners Asset Management AB lifted its holdings in shares of Evolent Health by 58.6% during the 4th quarter. Rhenman & Partners Asset Management AB now owns 230,000 shares of the technology company’s stock valued at $7,597,000 after acquiring an additional 85,000 shares in the last quarter. Finally, Pura Vida Investments LLC acquired a new position in shares of Evolent Health during the 4th quarter valued at $2,133,000.
Evolent Health Stock Performance
Shares of Evolent Health stock opened at $21.67 on Tuesday. The stock has a market capitalization of $2.52 billion, a P/E ratio of -17.34 and a beta of 1.44. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.57. The company has a 50-day simple moving average of $25.59 and a 200 day simple moving average of $29.40. Evolent Health, Inc. has a 12-month low of $20.54 and a 12-month high of $35.00.
Analyst Upgrades and Downgrades
Several research firms recently weighed in on EVH. JMP Securities reduced their target price on shares of Evolent Health from $38.00 to $34.00 and set a “market outperform” rating on the stock in a report on Friday, May 10th. Oppenheimer initiated coverage on shares of Evolent Health in a research report on Friday, March 1st. They set an “outperform” rating and a $45.00 price objective for the company. Citigroup initiated coverage on shares of Evolent Health in a research report on Monday, April 22nd. They issued a “buy” rating and a $40.00 target price for the company. JPMorgan Chase & Co. decreased their target price on shares of Evolent Health from $53.00 to $52.00 and set an “overweight” rating for the company in a research report on Friday, March 15th. Finally, Canaccord Genuity Group reduced their price target on shares of Evolent Health from $44.00 to $41.00 and set a “buy” rating for the company in a research note on Friday, May 10th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and eleven have assigned a buy rating to the stock. According to data from MarketBeat.com, Evolent Health currently has a consensus rating of “Moderate Buy” and an average target price of $42.00.
View Our Latest Stock Analysis on EVH
Evolent Health Company Profile
Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.
Read More
- Five stocks we like better than Evolent Health
- What is the NASDAQ Stock Exchange?
- Buffett Bails on BYD: What It Means for the Future of EV Stocks
- 3 Stocks to Consider Buying in October
- Domino’s vs. Papa John’s: Stock Showdown of Pizza Giants
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Williams-Sonoma Makes Stock More Accessible with a Stock Split
Receive News & Ratings for Evolent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health and related companies with MarketBeat.com's FREE daily email newsletter.